R(+)PPX High Dose Treatment of ALS

NCT00600873 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

INDIV

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: R(+) pramipexole dihydrochloride monohydrate

Sponsor

Bennett, James P., Jr., M.D., Ph.D.